Evaluation of follow-up observation using human epididymis protein 4, a tumor marker, in patients with ovarian cancer
Objective We evaluated the usefulness of human epididymis protein 4 (HE4), a tumor marker, during and after treatment in patients with ovarian cancer (OC). Methods We included Japanese patients newly diagnosed with OC treated at the National Cancer Center Hospital between 2014 and 2021. The HE4 leve...
Saved in:
Main Authors: | Masaya Uno (Author), Rie Matsuo (Author), Naoki Maezawa (Author), Tomoyasu Kato (Author) |
---|---|
Format: | Book |
Published: |
Korean Society of Obstetrics and Gynecology,
2023-07-01T00:00:00Z.
|
Subjects: | |
Online Access: | Connect to this object online. |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
Adenomatous tumor of epididymis. Case presentation
by: Tomás Lázaro Rodríguez Collar, et al.
Published: (2016) -
Association Between Micronutrient Concentrations and Human Epididymis Protein 4
by: Lim ZW, et al.
Published: (2021) -
Variations in procedures for ureterolysis with sharp dissection in minimally invasive hysterectomy
by: Yasuhito Tanase, et al.
Published: (2022) -
Pelvic seromucinous borderline tumor 26 years after ovarian seromucinous borderline tumor managed with post-treatment estrogen replacement therapy
by: Takashi Uehara, et al.
Published: (2021) -
Multiple biomarkers are more accurate than a combination of carbohydrate antigen 125 and human epididymis protein 4 for ovarian cancer screening
by: Kyung Nam Kang, et al.
Published: (2022)